Summary:
- Aquestive Therapeutics, a pharmaceutical company, has reported its financial results for the fourth quarter and full year 2024.
- The company's key highlights include increased revenue, reduced net loss, and progress in its pipeline of product candidates, including the development of a drug for the treatment of epilepsy.
- Aquestive Therapeutics is focused on developing innovative drug delivery solutions and advancing its pharmaceutical products to address unmet medical needs.